✦ LIBER ✦

Addition of paclitaxel to standard chemoradiotherapy for small-cell lung cancer beneficial

Book ID: 120865105
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2001
Weight: 134 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200113040-00047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-course induction chemoradiotherapy

Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer

✍ Thomas W Rice; David J Adelstein; Jay P Ciezki; Mark E Becker; Lisa A Rybicki; C 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 179 KB

New Radiotherapy and Chemoradiotherapy A

New Radiotherapy and Chemoradiotherapy Approaches for Non-Small-Cell Lung Cancer

✍ Salama, J. K.; Vokes, E. E. 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 930 KB

Addition of SRL 172 to standard chemothe

Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control

✍ Harper-Wynne, C.L.; Sumpter, K.; Ryan, C.; Priest, K.; Norton, A.; Ross, P.; For 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Polyglutamate paclitaxel conjugate promi

Polyglutamate paclitaxel conjugate promising for non-small-cell lung cancer and colorectal cancer

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 134 KB

Concurrent chemoradiotherapy for the syn

Concurrent chemoradiotherapy for the synchronous presentation of limited-stage small cell and early-stage non-small cell lung cancers

✍ John M. Watkins; Michael A. Yehl; David Holloman; Anand K. Sharma 📂 Article 📅 2010 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 244 KB

Prognostic value of dynamic MR imaging f

Prognostic value of dynamic MR imaging for non-small-cell lung cancer patients after chemoradiotherapy

✍ Yoshiharu Ohno; Munenobu Nogami; Takanori Higashino; Daisuke Takenaka; Sumiaki M 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 299 KB

## Abstract ## Purpose To determine the prognostic value of dynamic MRI for non‐small‐cell lung cancer (NSCLC) patients after chemoradiotherapy. ## Materials and Methods A total of 114 consecutive patients with NSCLC underwent dynamic MRI after chemoradiotherapy. The patients were divided into t